News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Protox Therapeutics Inc. Releases Q2 Financial Results And Company Highlights
August 29, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VANCOUVER, Aug. 29 /CNW/ - Protox(TM) Therapeutics Inc. (TSX-V:PRX) today reported financial results and operating highlights for the second quarter ended June 30, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Manufacturing
Roche pours $750M into Oregon manufacturing plant as obesity push expands
August 20, 2026
·
1 min read
·
Gabrielle Masson
IPO
Scribe’s early-stage IPO standout defies biotech’s derisking trend
August 20, 2026
·
3 min read
·
Gabrielle Masson
Rare diseases
Regeneron wins FDA approval to challenge Ipsen for rare bone disease market
August 20, 2026
·
2 min read
·
Nick Paul Taylor
Gene therapy
Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision
August 20, 2026
·
2 min read
·
Nick Paul Taylor
